Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
27.18
+0.16 (0.57%)
Feb 13, 2026, 9:59 AM EST - Market open
PBPH Holdings Information
PBPH is an equity ETF with a total of 54 individual holdings. The top holdings are Eli Lilly and Company stock at 14.19%, Johnson & Johnson at 9.30%, AbbVie at 6.34%, Roche Holding AG at 5.17%, and Novartis AG at 5.16%.
Total Holdings
54
Top 10 Percentage
61.97%
Asset Class
Equity
ETF Category
Health
Assets
52.30M
PE Ratio
22.11
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 14.19% |
| 2 | JNJ | Johnson & Johnson | 9.30% |
| 3 | ABBV | AbbVie Inc. | 6.34% |
| 4 | SWX: ROG | Roche Holding AG | 5.17% |
| 5 | SWX: NOVN | Novartis AG | 5.16% |
| 6 | MRK | Merck & Co., Inc. | 4.88% |
| 7 | LON: AZN | AstraZeneca PLC | 4.65% |
| 8 | AMGN | Amgen Inc. | 4.50% |
| 9 | GILD | Gilead Sciences, Inc. | 4.14% |
| 10 | CPH: NOVO.B | Novo Nordisk A/S | 3.63% |
| 11 | PFE | Pfizer Inc. | 3.54% |
| 12 | BMY | Bristol-Myers Squibb Company | 2.81% |
| 13 | LON: GSK | GSK plc | 2.66% |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | 2.62% |
| 15 | EPA: SAN | Sanofi | 2.53% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.71% |
| 17 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 1.34% |
| 18 | ASX: CSL | CSL Limited | 1.32% |
| 19 | ZTS | Zoetis Inc. | 1.30% |
| 20 | EBR: ARGX | argenx SE | 1.25% |
| 21 | ETR: BAYN | Bayer Aktiengesellschaft | 1.22% |
| 22 | LON: HLN | Haleon plc | 1.08% |
| 23 | ALNY | Alnylam Pharmaceuticals, Inc. | 0.96% |
| 24 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 0.88% |
| 25 | EBR: UCB | UCB SA | 0.83% |
As of Feb 10, 2026